Q3 2025 Management View Vivek Jain, CEO & Chairman, reported Q3 revenue of $533 million, representing 5% organic growth, with ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of ICU Medical ...

Medical device company ICU Medical (NASDAQ:ICUI) reported Q3 CY2025 results , but sales fell by 8.9% year on year to $537 ...

The mislabeled Potassium Chloride Inj. 20 mEq bags contain an overwrap label with Lot# 1023172 (NDC# 0990-7074-26) and an expiration date of 01-31-2026. ICU Medical is recalling 1 lot of Potassium ...

After unveiling plans last month to sell its medical device business for $2 billion, the U.K. technology group Smiths announced that a better deal has come along from a once-previous suitor. The ...

The major rain damage follows other problems at the beleaguered hospital, including a county ban on sending stroke patients ...

San Clemente-based ICU Medical Inc. (Nasdaq: ICUI) has completed its largest-ever acquisition, for fellow device maker Smiths Medical in a $2.4 billion cash and stock deal. ICU, a maker of devices for ...

ICU Medical Inc., a supplier of infusion therapy-related medical equipment, reported fourth quarter revenue and profit that topped analysts’ expectations. Yet, investors are unhappy, sending the stock ...

Fintel reports that on June 17, 2024, Raymond James upgraded their outlook for ICU Medical (NasdaqGS:ICUI) from Market Perform to Outperform. As of June 12, 2024, the average one-year price target for ...

ICU Medical recently faced investor concerns amid forecasts of a revenue decline and five consecutive years of decreasing earnings per share, reflecting ongoing operational challenges. This trend ...

ICU Medical develops disposable medical connection systems for use in intravenous (IV) therapy applications. The company's IV connectors are designed to prevent accidental disconnection of IV lines ...

Shares of ICU Medical (NASDAQ: ICUI), a medical device company specializing in intravenous treatment solutions, were on the move today following the announcement of a cash and stock deal for Smiths ...